10.3.2014

Gasum – Acquisition of Majority Stake in Norwegian Skangass to Make Gasum the Largest LNG Operator in the Nordics

Related services

We act as lead counsel to Gasum in the acquisition of a 51% majority in
Norwegian Skangass’s liquefied natural gas (LNG) distribution operations from Lyse Corporation. The Skangass production plant in Risavika will remain in Lyse’s ownership, but a long-term delivery contract regarding the use of the unit has been made with the new joint venture. Skangass’s Öra terminal in Norway, the Lysekil terminal still under construction and the planned Gävle terminal, both in Sweden, will be transferred to the joint venture.

The acquisition, which makes Gasum the largest Nordic LNG operator, is part of Gasum’s strategy of improving the availability of competitive LNG in Finland and taking a strong position in the growing Nordic LNG market overall. The formation of the joint venture will improve the availability of LNG, creating a distribution infrastructure in the Nordic countries, and broadly benefit the present and future needs of the marine traffic, heavy duty traffic, and the industrial clients currently outside the natural gas grids.

Our team

Latest references

Oomi – Transfer of KSS Energia’s electricity sales contracts for consumer and business customers to Oomi

We are advising Oomi Oy in a business transaction whereby KSS Energia Oy’s consumer and business customers in the retail sale of electricity will be transferred to Oomi. The transfer is scheduled to take place in March 2025. The arrangement requires approval from the Finnish Competition and Consumer Authority. Oomi Oy is one of the largest energy service companies and electricity sellers in Finland. The arrangement is a result of the recent development of the electricity market and Oomi’s strategy, which aims to offer customers a seamless and improved digital customer experience.

Fortum – Acquisition of a project development portfolio for renewable power from Enersense

We are acting as a counsel to Fortum in a transaction in which Fortum is strengthening its renewable power project pipeline through the acquisition of a project development portfolio from Enersense. The debt-and-cash free purchase price is approximately EUR 9 million, with the potential for project-specific earn-outs subject to projects successfully reaching a final investment decision in the future. The transaction is subject to customary closing conditions and is expected to be completed during the first quarter of 2025. Fortum is a leading Nordic energy company with the purpose to power a world where people, businesses and nature thrive together. Fortum’s core operations comprise of efficient, CO2-free power generation as well as reliable supply of electricity and district heat to private and business customers. The company is listed on Nasdaq Helsinki. One of Fortum’s strategic targets is to develop at least 800 MW of ready-to-build onshore wind and solar projects by the end of 2026.

Hanza AB – Acquisition of Leden Group

We are acting as Finnish advisor to Hanza AB relating to its acquisition of all the shares in Leden Group Oy. Hanza AB is a Swedish mechanical engineering and electronics contract manufacturing company listed on the Stockholm Stock Exchange. Founded in 2008, the company has six manufacturing clusters in Sweden, Finland, Germany, Baltics, Central Europe and China and an annual turnover of approximately SEK 4.6 billion. Leden Group is a leading Finnish contract manufacturer specialising in sheet metal, machining and complex assembly. Leden Group has four production sites in Finland and one in Estonia and an annual turnover of approximately SEK 1.1 billion. The closing of the transaction remains subject to authority approval and customary conditions.

Pharmaca Health Intelligence – Acquisition of PODIUM Connect and PODIUM Visits businesses

We assisted Pharmaca Health Intelligence in its acquisition of Mediaattori Ltd’s PODIUM Connect® and PODIUM Visits businesses. Through the acquisition, Pharmaca Health Intelligence strengthens its extensive service offerings in medical information, data-driven management, and education for both healthcare and pharmaceutical companies. Pharmaca Health Intelligence is a pioneer in digital medical information and a reliable partner for wellbeing services counties, the private healthcare sector and pharmacies. The company invests in the development of technology and service solutions related to pharmaceutical information, also on an international scale.

Search from the site.